Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

102.33
-0.5900-0.57%
Volume:219.49K
Turnover:22.48M
Market Cap:4.65B
PE:49.92
High:104.05
Open:104.05
Low:101.84
Close:102.92
52wk High:109.57
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:0.42
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.56
PE(LYR):49.92

Loading ...

U.S. Research Roundup-Broadcom, Deere & Co, Snowflake

Reuters
·
Yesterday

BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan

GlobeNewswire
·
Aug 25

Haemonetics Price Target Raised to $119.00/Share from $96.00 by Baird

Dow Jones
·
Aug 21

Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating

MT Newswires Live
·
Aug 19

Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma

MT Newswires Live
·
Aug 19

Haemonetics rises 15.2%

TIPRANKS
·
Aug 18

Haemonetics is Maintained at Buy by BTIG

Dow Jones
·
Aug 18

Haemonetics: CSL Plasma Migration Deal Highlights Long-Term Upside but Near-Term Risk/Reward Keeps Rating at Hold

TIPRANKS
·
Aug 18

Haemonetics Corp : Bofa Global Research Raises Price Objective to $120 from $100

THOMSON REUTERS
·
Aug 18

Haemonetics Corp - Enters Supply Agreement with CSL Plasma on August 14, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 18

Haemonetics Corp - CSL May Use Co.'S Nexsys Pcs Devices with Persona Plus Technology & Purchase Related Disposables in U.S. - SEC Filing

THOMSON REUTERS
·
Aug 18

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

Reuters
·
Aug 18

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching

Simply Wall St.
·
Aug 17

BofA Securities Adjusts Price Target on Haemonetics to $100 From $93

MT Newswires Live
·
Aug 13

BofA Securities Adjusts Haemonetics Price Target to $100 From $93

MT Newswires Live
·
Aug 12

Press Release: Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 12

Haemonetics Lifts Outlook on Broad-Based Earnings Strength

TIPRANKS
·
Aug 10

Haemonetics Price Target Raised to $92.00/Share from $79.00 by Citigroup

Dow Jones
·
Aug 08

Barrington Research Adjusts Haemonetics PT to $95 From $89, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07